Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Behavioural Brain Research
|
February 6, 2020
Ketamine: Leading us into the future for development of antidepressants
Flavia R Carreno, Daniel J Lodge, Alan Frazer
Basic & Clinical Pharmacology & Toxicology
|
August 19, 2007
[(3)H] citalopram binding to serotonin transporter sites in minnow brains
Georgianna G Gould, Bryan W Brooks, Alan Frazer
Journal of Affective Disorders
|
September 9, 2009
Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements
Martin M Katz, Charles L Bowden, Alan Frazer
The International Journal of Neuropsychopharmacology
|
April 4, 2001
New views of biogenic amine transporter function: implications for neuropsychopharmacology
Alan Frazer, Greg A. Gerhardt, Lynette C. Daws
Biological Psychiatry
|
May 3, 2006
Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain
Georgianna G Gould, Martin A Javors, Alan Frazer
The International Journal of Neuropsychopharmacology
|
January 16, 2014
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance
Saloua Benmansour, Anthony A Privratsky, Opeyemi S Adeniji, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2006
Leptin: a potential novel antidepressant
Xin-Yun Lu, Chung Sub Kim, Alan Frazer, et al.
Neuroendocrinology
|
July 11, 2015
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats
Saloua Benmansour, Opeyemi S Adeniji, Anthony A Privratsky, et al.
The International Journal of Neuropsychopharmacology
|
May 10, 2001
The International Journal of Neuropsychopharmacology
Bernard Lerer, Alan Frazer, Stephen Stahl, et al.
Journal of Clinical Psychopharmacology
|
April 16, 2015
Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies
Martin M Katz, Nancy Berman, Charles L Bowden, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Behavioural Brain Research
|
February 6, 2020
Ketamine: Leading us into the future for development of antidepressants
Flavia R Carreno, Daniel J Lodge, Alan Frazer
Basic & Clinical Pharmacology & Toxicology
|
August 19, 2007
[(3)H] citalopram binding to serotonin transporter sites in minnow brains
Georgianna G Gould, Bryan W Brooks, Alan Frazer
Journal of Affective Disorders
|
September 9, 2009
Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements
Martin M Katz, Charles L Bowden, Alan Frazer
The International Journal of Neuropsychopharmacology
|
April 4, 2001
New views of biogenic amine transporter function: implications for neuropsychopharmacology
Alan Frazer, Greg A. Gerhardt, Lynette C. Daws
Biological Psychiatry
|
May 3, 2006
Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain
Georgianna G Gould, Martin A Javors, Alan Frazer
The International Journal of Neuropsychopharmacology
|
January 16, 2014
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance
Saloua Benmansour, Anthony A Privratsky, Opeyemi S Adeniji, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 21, 2006
Leptin: a potential novel antidepressant
Xin-Yun Lu, Chung Sub Kim, Alan Frazer, et al.
Neuroendocrinology
|
July 11, 2015
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats
Saloua Benmansour, Opeyemi S Adeniji, Anthony A Privratsky, et al.
The International Journal of Neuropsychopharmacology
|
May 10, 2001
The International Journal of Neuropsychopharmacology
Bernard Lerer, Alan Frazer, Stephen Stahl, et al.
Journal of Clinical Psychopharmacology
|
April 16, 2015
Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies
Martin M Katz, Nancy Berman, Charles L Bowden, et al.
Page
of 5